Arabic Mobile Application for Multiple Sclerosis (MS) Patients and Its Effect on Their Quality of Life and Self-care Practices
Arabic app trial for MS patients tests quality of life and self-care
Plain English Summary
mHealth Effect on Multiple Sclerosis Patients' Quality of Life and Self-care Practices is a Not Applicable clinical trial sponsored by Cairo University studying Multiple Sclerosis. Tests if a new Arabic mobile app improves self-care and quality of life for people with Multiple Sclerosis. This trial is for adults aged 18-50 diagnosed with Multiple Sclerosis who own a smartphone. Participants will either use the app for 3 months or receive standard care, with follow-ups. The alternative is standard care without the use of the new mobile application. The trial aims to enroll 74 participants.
Official Summary
The goal of this clinical trial is to learn if an Arabic mobile application for multiple sclerosis patients will improve self-care practice and the quality of life of patients or not. The main question it aims to answer is: Does the Arabic mobile application for MS patients will improve their self-care and quality of life? Participants will: Use the developed application or usual care without using the application for 3 months Be followed up during the 12 week period and asked to follow the instructions in the application
Who Can Participate
Here is what you need to know about eligibility for this trial. You can join if you have been clinically diagnosed with Multiple Sclerosis. You must be between 18 and 50 years old and own a smartphone. You cannot join if you are bedridden, use a wheelchair, or are unable to read and write. This trial is studying Multiple Sclerosis, so participants generally need a confirmed diagnosis.
What They're Measuring
The study will measure how the app affects patients' ability to manage their own health and how it impacts their overall well-being. The specific primary outcome measures are: The effect of mHealth on the self-care practices of multiple sclerosis patients (From enrollment to the end of follow-up at 12 weeks); The effect of mHealth on the quality of life of multiple sclerosis patients (From enrollment to the end of follow-up at 12 weeks). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial addresses a need for accessible digital tools to help Multiple Sclerosis patients manage their condition and improve their daily lives. This research targets Multiple Sclerosis, where improved treatment options are needed.
Investor Insight
This trial explores the use of mHealth for chronic disease management, a growing area with potential for widespread adoption in the Middle East and North Africa region.
Is This Trial Right for Me?
Ask your doctor if this app is right for you and how it fits with your current treatment plan. You will use the app daily for 3 months, focusing on information about nutrition, exercise, mental health, and tracking symptoms or medications. You will be monitored for 12 weeks to see how the app affects your self-care and quality of life. The trial is being conducted at 1 site. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: INTERVENTIONAL
- Allocation: RANDOMIZED
- Model: PARALLEL
- Masking: NONE
- Enrollment: 74 participants
Interventions
- OTHER: My Journey with MS application — This is an Arabic application for MS patients that provides them with information about self-care like nutrition, exercise, mental health, and self-management, in addition to other features like symptom tracking and medication reminders.
Primary Outcomes
- The effect of mHealth on the self-care practices of multiple sclerosis patients (From enrollment to the end of follow-up at 12 weeks)
- The effect of mHealth on the quality of life of multiple sclerosis patients (From enrollment to the end of follow-up at 12 weeks)
Secondary Outcomes
- The usability of the developed application (After 12 weeks of enrollment)
Full Eligibility Criteria
Inclusion Criteria: * Diagnosed clinically with multiple sclerosis. * From 18 to 50 years old (adult). * With smartphones. * Willing to participate in the study and use the mobile application. Exclusion Criteria: * Patients who are bedridden or in a wheelchair * Illiterate patients.
Trial Locations
- Faculty of Medicine, Cairo University, Giza, Egypt
Frequently Asked Questions
What is clinical trial NCT06769763?
NCT06769763 is a Not Applicable INTERVENTIONAL study titled "mHealth Effect on Multiple Sclerosis Patients' Quality of Life and Self-care Practices." It is currently completed and is sponsored by Cairo University. The trial targets enrollment of 74 participants.
What conditions does NCT06769763 study?
This trial investigates treatments for Multiple Sclerosis. The primary condition under study is Multiple Sclerosis.
What treatments are being tested in NCT06769763?
The interventions being studied include: My Journey with MS application (OTHER). This is an Arabic application for MS patients that provides them with information about self-care like nutrition, exercise, mental health, and self-management, in addition to other features like symptom tracking and medication reminders.
What does Not Applicable mean for NCT06769763?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT06769763?
This trial is currently "Completed." It started on 2025-01-14. The estimated completion date is 2025-09-15.
Who is sponsoring NCT06769763?
NCT06769763 is sponsored by Cairo University. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT06769763?
The trial aims to enroll 74 participants. The trial status is completed.
How is NCT06769763 designed?
This is a interventional study, uses randomized allocation, follows a parallel design, employs none masking.
What are the primary outcomes being measured in NCT06769763?
The primary outcome measures are: The effect of mHealth on the self-care practices of multiple sclerosis patients (From enrollment to the end of follow-up at 12 weeks); The effect of mHealth on the quality of life of multiple sclerosis patients (From enrollment to the end of follow-up at 12 weeks). These are the main endpoints researchers use to determine whether the treatment is effective.
Where is NCT06769763 being conducted?
This trial is being conducted at 1 site, including Giza (Egypt).
Where can I find official information about NCT06769763?
The official record for NCT06769763 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT06769763. This government database provides the most up-to-date and detailed information about the trial.
What is NCT06769763 testing in simple terms?
Tests if a new Arabic mobile app improves self-care and quality of life for people with Multiple Sclerosis. This trial is for adults aged 18-50 diagnosed with Multiple Sclerosis who own a smartphone.
Why is this trial significant?
This trial addresses a need for accessible digital tools to help Multiple Sclerosis patients manage their condition and improve their daily lives.
What are the potential risks of participating in NCT06769763?
Potential side effects are minimal and may include minor app-related issues or frustration. The main risk is that the app may not be effective for everyone or may not fit your specific needs. Participants who are bedridden or in wheelchairs are excluded, suggesting potential challenges with app accessibility for severely impaired individuals. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT06769763?
Ask your doctor if this app is right for you and how it fits with your current treatment plan. You will use the app daily for 3 months, focusing on information about nutrition, exercise, mental health, and tracking symptoms or medications. You will be monitored for 12 weeks to see how the app affects your self-care and quality of life. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT06769763 signal from an investment perspective?
This trial explores the use of mHealth for chronic disease management, a growing area with potential for widespread adoption in the Middle East and North Africa region. This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participants will either use the app for 3 months or receive standard care, with follow-ups. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Multiple Sclerosis Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.